Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a rare and highly aggressive tumor. Nivolumab showed durable antitumor effect in patients with recurrent MPM and was approved for those patients in Japan in 2018. Immune related adverse event (irAE) is occurred in various organs and is suggestive to be related...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Med Case Rep
Main Authors: Sakakibara-Konishi, Jun, Sato, Mineyoshi, Sato, Michiko Takimoto, Kasahara, Kohei, Onozawa, Masahiro, Mizugaki, Hidenori, Kikuchi, Eiki, Asahina, Hajime, Shinagawa, Naofumi, Konno, Satoshi
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378269/
https://ncbi.nlm.nih.gov/pubmed/32714828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados